APSR2026-871

 
Late-Breaking
Submitted
Poster Presentation
 
AP11-022
P64
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1220934-46904-APSR2026_AP11-022_poster_A0_439717.pdf
Format: PDF Only
09. Asthma
15

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Densenbal Dansran * Mongolian National University of Medical Sciences Department of Pulmonary and Allergy School of Medicine Ulaanbaatar Mongolia
Tumen-Ulzii Gankhuyag - Mongolian National University of Medical Sciences Department of Pulmonary and Allergy School of Medicine Ulaanbaatar Mongolia
Solongo Bandi - Mongolian National University of Medical Sciences Department of Pulmonary and Allergy School of Medicine Ulaanbaatar Mongolia
Ichinnorov Dashtderen - Mongolian National University of Medical Sciences Department of Pulmonary and Allergy School of Medicine Ulaanbaatar Mongolia
Ankhbold Gombodorj - Sukhbaatar district Hospital Department of Administration Ulaanbaatar Mongolia
Amarsanaa Otgonbayar - Shargaljuut LLC Department of Administration Ulaanbaatar Mongolia
Amartuvshin Ganbold - Mongolian National University of Medical Sciences Department of Pulmonary and Allergy School of Medicine Ulaanbaatar Mongolia
Manaljav Tseden-Ish - Mongolian National University of Medical Sciences Department of Pulmonary and Allergy School of Medicine Ulaanbaatar Mongolia
Battsengel Tsedendamba - First State Hospital Mongolia Center of Pulmonary and Allergy Ulaanbaatar Mongolia
Odonchimeg Bayar - First State Hospital Mongolia Center of Pulmonary and Allergy Ulaanbaatar Mongolia
Tseepil Enebish - Second State Hospital Department of Pulmonary medicine Ulaanbaatar Mongolia
Janchivdorj Zagdsuren - Mongolian National University of Medical Sciences Department of Pulmonary and Allergy Ulaanbaatar Mongolia
Ankhil Lhagvasuren - UB med Hospital Department of Internal Medicine Ulaanbaatar Mongolia
Dorjkhand Altankhundag - UB med Hospital Department of Internal Medicine Ulaanbaatar Mongolia
Otgonjargal Gurjav - Mongolian Japan Hospital Department of Outpatient Ulaanbaatar Mongolia
Presenting Author Details
Densenbal
Dansran
densenbal@mnums.edu.mn
+97699082522
41-50
Mongolia
Original Research
Association between inflammatory biomarkers and clinical and functional outcomes following balneotherapy in patients with asthma
Maximum 25 words
Abstract Content
Balneotherapy, defined as the therapeutic use of mineral-rich thermal water, has been reported to improve asthma symptoms and functional capacity. However, the relationship between inflammatory biomarkers and clinical and functional outcomes following balneotherapy remains unclear.
A prospective study included 93 patients with asthma (mean age 52.1 ± 12.4 years; 76.3% female). Clinical outcomes included the Asthma Control Test (ACT), Asthma Quality of Life Questionnaire (AQLQ), 6-minute walk test (6MWT), and Borg dyspnea scale. Laboratory parameters included eosinophil-to-lymphocyte ratio (ELR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), eosinophil-to-neutrophil ratio (ENR), and immunoglobulin E (IgE). Patients underwent a 10-day course of balneotherapy using thermal mineral water at the Shargaljuut spa resort combined with standard preventive asthma treatment. Assessments were performed before treatment and at 1-month follow-up. Changes were analyzed using non-parametric tests, and associations were evaluated using Spearman correlation analysis.
At 1 month, asthma control significantly improved (p = 0.016), 6MWT distance increased (p < 0.05), Borg scores decreased (p < 0.001), and AQLQ scores improved (p < 0.001). ELR significantly decreased (p < 0.001), while PLR showed a borderline increase (p ≈ 0.05). No significant changes were observed in SII, NLR, ENR, or IgE (all p > 0.05). Stratified analysis showed improvements in ELR, 6MWT, Borg, and AQLQ in well-controlled and partly controlled asthma groups (all p < 0.01), whereas no significant changes were observed in the poorly controlled group. No significant correlations were found between laboratory markers and clinical or functional outcomes.
Balneotherapy improved clinical and functional outcomes and reduced eosinophilic inflammation in patients with asthma; however, inflammatory biomarkers were not directly associated with clinical improvement.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Asthma; balneotherapy; inflammatory biomarkers; ELR; ACT; AQLQ; 6MWT
maximum 3 keywords and no abbreviations, separated by commas
 
271